Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Topoisomerase Assays

View through CrossRef
AbstractTopoisomerases are enzymes that play essential roles in DNA replication, transcription, chromosome segregation, and recombination. All cells have two major forms of DNA topoisomerases: type I enzymes, which make single‐stranded cuts in DNA, and type II enzymes, which cut and decatenate double‐stranded DNA. DNA topoisomerases are important targets of approved and experimental anti‐cancer agents. Provided in this article are protocols to assess activities of topoisomerases and their inhibitors. Included are an assay for topoisomerase I activity based on relaxation of supercoiled DNA; an assay for topoisomerase II based on the decatenation of double‐stranded DNA; and approaches for enriching and quantifying DNA‐protein covalent complexes formed as obligatory intermediates in the reactions of type I and II topoisomerases with DNA; and assays for measuring DNA cleavagein vitro. Topoisomerases are not the only proteins that form covalent adducts with DNA in living cells, and the approaches described here are likely to find use in characterizing other protein‐DNA adducts and exploring their utility as targets for therapy. © 2021 Wiley Periodicals LLC.Basic Protocol 1: Assay of topoisomerase I activityBasic Protocol 2: Assay of topoisomerase II activityBasic Protocol 3:In vivodetermination of topoisomerase covalent complexes using thein vivocomplex of enzyme (ICE) assaySupport Protocol 1: Preparation of mouse tissue for determination of topoisomerase covalent complexes using the ICE assaySupport Protocol 2: Using recombinant topoisomerase standard for absolute quantification of cellular TOP2CCBasic Protocol 4: Quantification of topoisomerase‐DNA covalent complexes by RADAR/ELISA: The rapid approach to DNA adduct recovery (RADAR) combined with the enzyme‐linked immunosorbent assay (ELISA)Basic Protocol 5: Analysis of protein‐DNA covalent complexes by RADAR/WesternSupport Protocol 3: Adduct‐Seq to characterize adducted DNASupport Protocol 4: Nuclear fractionation and RNase treatment to reduce sample complexityBasic Protocol 6: Determination of DNA cleavage by purified topoisomerase IBasic Protocol 7: Determination of inhibitor effects on DNA cleavage by topoisomerase II using a plasmid linearization assayAlternate Protocol: Gel electrophoresis determination of topoisomerase II cleavage
Title: Topoisomerase Assays
Description:
AbstractTopoisomerases are enzymes that play essential roles in DNA replication, transcription, chromosome segregation, and recombination.
All cells have two major forms of DNA topoisomerases: type I enzymes, which make single‐stranded cuts in DNA, and type II enzymes, which cut and decatenate double‐stranded DNA.
DNA topoisomerases are important targets of approved and experimental anti‐cancer agents.
Provided in this article are protocols to assess activities of topoisomerases and their inhibitors.
Included are an assay for topoisomerase I activity based on relaxation of supercoiled DNA; an assay for topoisomerase II based on the decatenation of double‐stranded DNA; and approaches for enriching and quantifying DNA‐protein covalent complexes formed as obligatory intermediates in the reactions of type I and II topoisomerases with DNA; and assays for measuring DNA cleavagein vitro.
Topoisomerases are not the only proteins that form covalent adducts with DNA in living cells, and the approaches described here are likely to find use in characterizing other protein‐DNA adducts and exploring their utility as targets for therapy.
© 2021 Wiley Periodicals LLC.
Basic Protocol 1: Assay of topoisomerase I activityBasic Protocol 2: Assay of topoisomerase II activityBasic Protocol 3:In vivodetermination of topoisomerase covalent complexes using thein vivocomplex of enzyme (ICE) assaySupport Protocol 1: Preparation of mouse tissue for determination of topoisomerase covalent complexes using the ICE assaySupport Protocol 2: Using recombinant topoisomerase standard for absolute quantification of cellular TOP2CCBasic Protocol 4: Quantification of topoisomerase‐DNA covalent complexes by RADAR/ELISA: The rapid approach to DNA adduct recovery (RADAR) combined with the enzyme‐linked immunosorbent assay (ELISA)Basic Protocol 5: Analysis of protein‐DNA covalent complexes by RADAR/WesternSupport Protocol 3: Adduct‐Seq to characterize adducted DNASupport Protocol 4: Nuclear fractionation and RNase treatment to reduce sample complexityBasic Protocol 6: Determination of DNA cleavage by purified topoisomerase IBasic Protocol 7: Determination of inhibitor effects on DNA cleavage by topoisomerase II using a plasmid linearization assayAlternate Protocol: Gel electrophoresis determination of topoisomerase II cleavage.

Related Results

Abstract 1757: Elesclomol (STA-4783) is a potent inhibitor of topoisomerase II
Abstract 1757: Elesclomol (STA-4783) is a potent inhibitor of topoisomerase II
Abstract Elesclomol (STA-4783; N’1, N’3-dimethyl-N’1, N’3- bis(phenylcarbonothioyl)propanedihydrazide) is an anticancer drug that has received both fast track and or...
The topoisomerase II/condensin II axis silences transcription during germline specification in Caenorhabditis elegans
The topoisomerase II/condensin II axis silences transcription during germline specification in Caenorhabditis elegans
Abstract In Caenorhabditis elegans, the germline is specified via a preformation mechanism that relies on the PIE-1 protein's ability to globally silence mRNA transc...
Analysis of topoisomerase II‐mediated DNA cleavage of the c‐myc gene during HL60 differentiation
Analysis of topoisomerase II‐mediated DNA cleavage of the c‐myc gene during HL60 differentiation
We have investigated the effect of mAMSA, a potent topoisomerase II inhibitor, on the c‐myc proto‐oncogene of the acute promyelocytic leukemia HL60 cell line during its differentia...
A Mini Review of Novel Topoisomerase II Inhibitors as Future Anticancer Agents
A Mini Review of Novel Topoisomerase II Inhibitors as Future Anticancer Agents
Several reviews of inhibitors of topoisomerase II literature have been published covering research before 2018. Therefore, this review is focused primarily on more recent publicati...
Einfluss von (‐)‐Epigallocatechin‐3‐gallat auf Enzyme der Klassen der Histondeacetylasen und Topoisomerasen in Zellmodellen
Einfluss von (‐)‐Epigallocatechin‐3‐gallat auf Enzyme der Klassen der Histondeacetylasen und Topoisomerasen in Zellmodellen
Zusammenfassung(‐)‐Epigallocatechin‐3‐gaNat (EGCG) gehört zu der Gruppe der Catechine, welche 30‐40 % der festen Bestandteile von grünem Tee ausmachen. Eine Vielzahl von gesundheit...
Embryotoxicity of the intercalating agents m‐AMSA and o‐AMSA and the epipodophyllotoxin VP‐16 in postimplantation rat embryos in vitro
Embryotoxicity of the intercalating agents m‐AMSA and o‐AMSA and the epipodophyllotoxin VP‐16 in postimplantation rat embryos in vitro
AbstractThe intercalating agent, m‐AMSA, and the epipodophyllotoxin, VP‐16, both topoisomerase II—reactive anticancer agents, are also embryotoxic agents in rat embryos cultured in...

Back to Top